Prisma Health Transplant Center Launches Liver Transplant Program

The addition of liver transplant services expands local accessibility to lifesaving treatment.

GREENVILLE, S.C. – The Prisma Health Transplant Center announces an expansion of service in Greenville to bring a new option to South Carolina patients who may be candidates for liver transplant. Patients who otherwise would need to travel hours to transplant centers in the region will now be able to receive care much closer to home. The Prisma Health liver transplant program received approval from the United Network for Organ Sharing (UNOS) in June, has already completed its first liver transplant procedure and has listed more candidates who may begin their liver transplant journey soon.

By offering transplant services to the Upstate and surrounding regions, Prisma Health provides advanced, quality healthcare while easing the travel burden felt by patients and their families over the course of the transplant journey, from early evaluation to preparation, through the donor process, to surgery and follow-up care. The program serves patients with a variety of liver conditions, ranging from acute and chronic liver failure to various cancers.

Dr. Derek DuBay, nationally recognized transplant surgeon and liver transplant program leader, said, “I’m privileged to be part of a team dedicated to expanding access to liver transplant services in this region so more patients can find the hope and expertise they need closer to home. Our specialists guide and encourage patients facing a scary diagnosis in their journey toward becoming a transplant recipient. Helping each patient achieve a successful outcome resulting in longer and improved quality of life is what inspires us every day.”

The Prisma Health Transplant Center at Greenville Memorial Hospital is led by physicians with a combined 45 years of experience caring for liver transplant patients and is one of only 256 transplant centers nationwide. It is one of only three centers in all of South Carolina.

In response to rising need, Prisma Health first launched the Transplant Center in 2022 to offer a solid organ transplant program which has expanded to include kidney and pancreas transplant services, and now, liver transplant. Since opening, the Transplant Center has seen steady growth. The team has completed 350 solid organ transplant procedures and provides comprehensive follow-up for patients.

Southern states have some of the highest liver disease mortality rates with South Carolina ranking high among them. The most common risk factors for liver disease include obesity, Type 2 diabetes and alcohol use. According to the U.S. Centers for Disease Control, 1,096 South Carolinians died of liver disease in 2021. Liver failure was the 9th leading cause of death in the state. In 2023, 58 liver transplants were performed in the state. The liver transplant “need” in South Carolina is estimated at over 150 each year. 

Prisma Health’s team of transplant specialists, hepatologists, surgeons and dedicated caregivers work closely with each patient to develop a personalized treatment plan, ensuring the best possible outcome. With access to innovative treatments and state-of-the-art technology, we are committed to helping patients live longer, healthier lives.

Learn more about the Prisma Health Transplant Center at PrismaHealth.org/LiverTransplant

About Prisma Health

Prisma Health is a private nonprofit health company with over 32,000 team members, 19 acute and specialty hospitals, 3,131 licensed beds, 320 practice sites, and more than 5,900 employed and independent clinicians across its clinically integrated inVio Health Network. Each year, Prisma Health serves more than 1.6 million patients in South Carolina and Tennessee. Connect with Prisma Health on Facebook,  InstagramLinkedIn and  Twitter/X.   

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.